Lenvatinib in radioiodine-refractory differentiated thyroid cancer: a real-world institutional analysis

Endocrine Journal · Published 2026-01-01 · DOI 10.1507/endocrj.ej25-0539

Authors being retrieved — see the publisher record. https://doi.org/10.1507/endocrj.ej25-0539

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Detection rate and maximum diameter of thyroid cysts among children and adolescents in thyroid ultrasound examination, The Fukushima Health Management Survey · Endocrine Journal · 2026 · Same journal
Nationwide survey on iodine nutritional status and thyroid function in Japanese adults · Endocrine Journal · 2026 · Same journal
From cross-section to prognosis: risk factors for renal function deterioration in primary hyperparathyroidism · Endocrine Journal · 2026 · Same journal
Acanthosis nigricans as a diagnostic clue for familial partial lipodystrophy type 2: a case report with review of literature on Japanese cases · Endocrine Journal · 2026 · Same journal
Indicators for predicting continuous insulin infusion therapy-related hypokalemia: multicenter retrospective cohort study · Endocrine Journal · 2026 · Same journal
Low-affinity IgG-mediated macro-TSH: diagnostic limitations of peak-based gel filtration chromatography—a case report with review of literature · Endocrine Journal · 2026 · Same journal
ICE2026/JES2026 Abstract Book · Endocrine Journal · 2026 · Same journal
Differentiating TRAb-positive painless thyroiditis from Graves’ disease using biochemical and ultrasound findings · Endocrine Journal · 2026 · Same journal
Adipose-derived stem cell exosomes mitigate ferroptosis and enhance osteogenesis via miR-215-5p-mediated ubiquitin-specific protease 1 suppression · Endocrine Journal · 2026 · Same journal
Short- and long-term prognostic analysis of supraclavicular oblique incision versus traditional low-collar incision in thyroidectomy · Endocrine Journal · 2026 · Same journal